FDA Inspection 1051625 — Margaret A. Keller PhD
The FDA completed an inspection of Margaret A. Keller PhD on Apr 25, 2018 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Philadelphia, PA (United States)
Additional Details
Clinical Investigator (CI)